Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125261592 | 12526159 | 2 | F | 201509 | 20160727 | 20160705 | 20160810 | PER | US-PFIZER INC-2016312154 | PFIZER | 60.00 | YR | M | Y | 0.00000 | 20160810 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125261592 | 12526159 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | 100 MG, 3X/DAY | Y | 20235 | 100 | MG | CAPSULE, HARD | TID | |||||
125261592 | 12526159 | 2 | SS | NEURONTIN | GABAPENTIN | 1 | Oral | 100 MG, 4X/DAY | Y | 20235 | 100 | MG | CAPSULE, HARD | QID | |||||
125261592 | 12526159 | 3 | SS | GRALISE | GABAPENTIN | 1 | 300 MG, 1X/DAY | Y | 0 | 300 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125261592 | 12526159 | 1 | Nerve injury |
125261592 | 12526159 | 3 | Nerve injury |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125261592 | 12526159 | Anger | |
125261592 | 12526159 | Feeling abnormal | |
125261592 | 12526159 | Irritability | |
125261592 | 12526159 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125261592 | 12526159 | 2 | 20150909 | 20160505 | 0 | |
125261592 | 12526159 | 3 | 20160516 | 20160701 | 0 |